The ability of certain azole substituted oligodeoxyribonucleotldes to promote antiparallel triple helix formation with duplex targets having CG or TA interruptions In the otherwise homopurine sequence was examined. 2-Deoxyribonucleosides of the azoles, which include pyrazole, imidazole, 1,2,4-triazole and 1,2,3,4-tetrazole were synthesized using the stereospecific sodium salt glycosylation procedure. These nucleosides were successfully incorporated using solid-support, phosphoramidite chemistry, Into oligonucleotides designed to Interact with the non-homopurine duplex targets. The interaction of these modified oligonucleotides with all four possible base pairs was evaluated and compared to similar data for a series of natural oligonucleotides. The oligonucleotides containing simple azoles enhanced the triplex forming ability considerably at non-homopurine targets. Binding of these modified oligonucleotides to duplex targets containing TA Inversion sites was particularly noteworthy, and compare favorably to unmodified oligonucleotides for binding to duplex targets containing CG as well as TA base pairs. The selectivity exhibited by certain azoles is suggestive of base pair specific interactions. Thus, the azoles evaluated during this study show considerable promise for efforts to develop generalized triplex formation at non-homopurine duplex sequences.
INTRODUCTION
Binding of oligonucleotides to appropriate duplex DNA targets can result in the formation of a local triple helix structure, or triplex (I -4). Ideally, the duplex portion of the triplex consists of a homopurine strand and a homopyrimidine strand. The third strand binds in the major groove of the duplex by hydrogen bonding to the purine bases in the homopurine strand. Several different types of triplexes have been described (1) . However, the triplex stability is often severely reduced by the presence of one or more pynmidines in the purine-nch strand of the duplex (5) (6) (7) (8) (9) (10) (11) (12) . This prevents triplex formation at mixed sequence duplex targets.
Numerous attempts have been made to extend triplex formation to include non-homopurine duplexes. One approach has been to test natural nucleosides to identify those that exhibit significant ability to bind to sites where a pynrrudine interrupts an otherwise homopurine region of a duplex (henceforth termed an inversion site). Examples of this include the parallel G»TA triplet (5, 11, (13) (14) (15) and the antiparallel T»CG triplet (9, 12) . However, these triplets are significantly less stable than the canonical ones. Stenc constraints imposed by CG or TA base pairs force natural nucleosides in the third strand to be displaced from the ideal position. Although favorable interactions may sometimes be accommodated, the disruption imposed by the steric problem is likely to limit the utility of natural nucleosides.
A second approach has been the de novo design of novel nucleoside analogs intended to bind to CG or TA base pairs (16) (17) (18) . Although this approach has had some success, the observed binding was not based on the formation of hydrogen bonded triplets, as originally proposed (19) . This is likely due to the difficulty of designing a complex nucleoside capable of binding to CG or TA base pairs with appropriate affinity and specificity.
An alternative approach has been to use non-nucleosidic linkers to connect separate oligonucleotides such that they can bind to nearby homopurine targets separated by a non-homopurine intervening sequence (20) (21) (22) (23) . A drawback of this approach is that there is no interaction between the linked oligonucleotides and the intervening sequence. In the case of a single pyrimidine embedded within a homopurine target, use of an ohgonucleotide containing a linker will disrupt potential stacking interactions across the inversion site. Thus, none of the current strategies for binding to non-homopunne targets is ideal.
We describe in this paper a unique approach to triplex formation at non-homopurine targets, utilizing the modified oligonucleotides containing simple azole 2'-deoxyribonucleo- 
MATERIALS AND METHODS

Nucleoside phosphoramidite synthesis
General procedure for glycosy lotion of azoles with the a-halogenose 2. To a solution of the azole (la-c, 7, 20 mmol) in dry CH 3 CN (200 ml) was added NaH (20 mmol, 80% dispersion in oil). After stirring the mixture at room temperature for 30 min, l-chloro-2-deoxy-3,5-di-O-/7-toluoyl-a-D-eryf/ur>-pentofuranose (2, 20 mmol) was added in four portions at 20 min intervals. After a total of 2 h starring, the solvent was evaporated and the residue was diluted with CH2Q2 (150 ml). The organic solution was washed with H2O (50 ml), and dried over anhydrous Na2SC>4. The solvent was evaporated and the residue was purified by chromatography on a silica gel column (2.5 x 25 cm) using a gradient of increasing concentration of EtOAc in CH2CI2 as the eluent to yield the corresponding blocked nucleosides (3a-c, 8,9) ( Table 1) .
General procedure for deblocking 3a-c and 9. The blocked nucleoside (7.12 mmol) was dissolved in MeOH/NH 3 (200 ml, MeOH saturated with NH3 at 0°C) and the mixture was stirred at room temperature for 18 h The solvent was evaporated and the residue was purified by chromatography on a silica gel column (2.5 x 15 cm) using a gradient of increasing concentration of MeOH in CH2CI2 to give the corresponding free nucleosides (4a-c, 10) ( Table 1) .
General procedure for 5'-O-tritylation of4a-c and 10. The free nucleoside (4.09 mmol) was dried by co-evaporation with dry pyridine (2 x 15 ml) and dissolved in dry pyridine (10 ml). 4,4'-Dimethoxytrityl chloride (DMT-C1, 1.8 g, 5.3 mmol) was added and the mixture was stirred at room temperature for 3 h under an argon atmosphere. The reaction mixture was diluted with CH2CI2 (150 ml) and the organic solution was washed with water (25 ml). The organic layer was dried (Na2SO4) and evaporated. The residue was co-evaporated with toluene (2 x 10 ml) to remove traces of pyridine. The product was purified by chromatography on a silica gel column (2.5 x 25 cm) using a gradient of increasing concentration of MeOH in CH2CI2 as the eluent to yield the corresponding 5'-0-(4,4'-dimethoxytrityl) derivatives (5a-c, 11) ( Table 1) .
General procedure for phosphitylation of 5a-c and 11. To a solution of the 5'-O-tntyl nucleoside (1.52 mmol) in a mixture of anhydrous CH2CI2 (15 ml) and MA'-diisopropylethylarnine (1.07 ml, 6.1 mmol) was added 2-cyanoethyl-A'^V-diisopropylchlorophosphorarrudite (0.43 ml, 1.98 mmol) under an argon atmosphere. After stirring the reaction mixture at ambient temperature for 30 min, it was diluted with EtOAc (50 ml) and the organic solution was washed with aqueous saturated NaHCO3 solution (30 ml). The organic layer was dried (Na2SO4) and evaporated to dryness. The residue was purified by chromatography on a silica gel column (2.5 x 10 cm) packed in a mixture of CH2CI2: EtOAc:NEt 3 (75:23:2, v/v). The product was eluted using the same solvent mixture and the eluate containing the desired product was collected and evaporated to dryness. The residue was dissolved in CH2CI2 (5 ml) and the solution was added slowly to rapidly stirred cold pentane (100 ml). The supernatant was decanted from the precipitated solid. The solid was dried in vacuo until free of residual solvents to yield the corresponding 3'-phosphoramidites (6a-c, 12) ( Table 1) .
Oligonucleotide synthesis
Phosphoramidites of deoxyguanosine and thymidine were purchased from Applied Biosystems or Glen Research. Pyrazole, imidazole, triazole and tetrazole 2'-deoxyribonucleosides were tested for their stability under DNA synthesis conditions before incorporating them into oligonucleotides. With the exception of pyrazole-2'-deoxyribonucleoside, all nucleosides were stable to synthesis and deblocking conditions (30% NH4OH, 56°C, 16 h). By TLC analysis, it appeared that 5-10% of the pyrazole-2'-deoxynbonucleoside was degraded under these conditions. In contrast, 16 h incubation in concentrated NH4OH at room temperature did not result in any detectable degradation of pyrazole-2'-deoxyribonucleoside. Oligonucleotides were synthesized on Applied Biosystems DNA synthesizers (models 380B or 394) employing the phosphoramidite methodology, on 0.2 or 1 mmol scale. Standard coupling times and phosphoramidite concentrations were used. Oligonucleotide 17, containing pyrazole-2'-deoxyribonucleoside, was prepared using the 2-A^-dimethylformarrudine-5'-O-DMT-3'-Ophosphoramidite of 2'-deoxyguanosine (Applied Biosystems).
Stepwise coupling efficiency for non-natural nucleosides ranged from 93 to 99%. After cleavage from the support with concentrated NH4OH at room temperature for 2 h, the oligomer was deblocked at room temperature overnight with concentrated NH4OH. All other oligonucleotides were prepared using dG phosphoramidites containing the standard 2-/V-isobutyryl blocking group, and were deblocked with concentrated NH4OH at 56°C for 16 h. Oligonucleotides were purified by denaturing 20% polyacrylamide, 7 M urea, gel electrophoresis and desalted using C18 Sep-Pack (Waters) column. Aliquots of purified oligonucleotides were analyzed by gel electrophoresis to confirm the expected length and purity.
Oligonucleotides containing azole nucleosides were analyzed by electrospray mass spectrometry. Observed molecular weights were withinO.013% of the calculated values. We further analyzed a pentamer containing imidazole using fast atom bombardment mass spectrometry. The molecular ion had the expected molecular weight, and analysis of the fragmentation pattern demonstrated the presence and position of a nucleoside monophosphate with a molecular weight identical to that expected for irrudazole-2'-deoxynbonucleoside monophosphate These data were taken as evidence that the nucleosides in this study could be routinely incorporated into oligonucleotides without substantial degradation or modification.
Binding assays
Duplex DNA targets were prepared by annealing complementary single stranded oligonucleotides and purifying by nondenaturing polyacrylamide gel electrophoresis. Duplexes were labeled using polynucleotide kinase and [y- sucrose, and incubating for 24-48 h at 37°C. Samples were separated on polyacrylamide gels buffered with TBM (4). The radioactivity in the duplex and triplex bands was quantified using a Beta-Scope, corrected for background, and plotted as:
f tnplex c-P-m.dupic, + c.p.m. mpte , Data points were fit to the equation
where Fjat is the apparent fraction triplex at saturating amounts of third strand, K is the apparent macromolecular association constant for triplex formation, and O tot is the total concentration of added third strand oligonucleotide. F^t ranged from 0.75 to 1 0, with most values in the 0.85-0.9 range. This equation assumes that the total added third strand oligonucleotide is always in substantial excess over labelled duplex. The curve fitting function of SigmaPlot was used to determine best fit values for Fsat and K. Values reported in Table 2 and depicted in Figure 5 are the K values determined by this procedure.
RESULTS AND DISCUSSION
Synthesis of non-natural nucleosides Figure 1 shows the non-natural nucleosides evaluated in this study. These include 2'-deoxynbofuranosyl derivatives of pyrazole (4a), imidazole (4b), 1,2,4-triazole (4c) and 1,2,3,4-tetrazole (10). Several criteria were considered in selecting these analogues. Their small size and lack of exocychc functional groups should minimize potential steric clash with bases of the duplex at sites of CG or TA inversion. The number and position of ring nitrogens was varied to empirically determine the optimal arrangement for potential stacking, electrostatic and hydrogen bonding interactions.
Total synthesis of the azole nucleosides was achieved by utilizing the stereospecific sodium salt glycosylation procedure (24) . Thus, reaction of the sodium salt of pyrazole (la) or imidazole (lb) (generated in situ by the treatment with NaH) with l-chloro-2-deoxy-3,5-di-0-/>-toluoyl-a-D-ery^w-pentofuranose (2) (25) in dry acetomtnle (CH3CN) afforded the corresponding protected nucleosides (3a and 3b) (Fig. 2) . Removal of the protecting toluoyl groups of 3a and 3b was accomplished by the treatment with methanolic ammonia at ambient temperature and the corresponding free nucleosides 4a and 4b were isolated in good yields. The free nucleosides were converted to the corresponding 5'-O-(4,4'-dimethoxytntyl) derivatives by treatment with 4,4'-dimethoxytrityl chloride (DMT-C1) in anhydrous pyridine. Purification of the reaction product by silica gel column chromatography provided pure 5a and 5b Conventional phosphitylation of 5a and 5b with 2-cyanoethyl-yvVV-diisopropylchlorophosphoramidite in CH2CI2 in the presence of NJVdiisopropylethylamine gave the corresponding phosphoramidites 6a and 6b
In the case of pyrazole and imidazole, glycosylation at either ring nitrogen results in identical compounds. However, in the case of tnazole (lc) or tetrazole (7), glycosylation could lead to the formation of two positional isomers. Reaction of the sodium salt of lc with 2 in dry CH3CN, work-up and purification of the reaction mixture by silica gel column chromatography gave mainly the positional isomer 3c. The structure of 3c was readily apparent since two singlets (each for C3H and C5//) were observed in the ' H NMR spectrum at 5 8.03 and 8.69, establishing N 1 as the site of glycosylation (26) . The 'H NMR spectrum of the isomenc 4-(2-deoxy-p^D-eryf/ira-pentofuranosyl)-1,2,4-triazole is expected to exhibit a singlet for the C3 and C5 protons due to symmetry (27) . Toluoyl protecting groups of 3c were removed to give the free nucleoside (4c), which was converted to the target phosphoramidite (6c) via the intermediate 5c by the conventional procedure.
Treatment of the sodium salt of tetrazole (7) with 2 in dry CH3CN gave a reaction mixture comprising two positional isomers (8 and 9, Fig. 3 ) These were separated by silica gel column chromatography. NOE enhancement studies (28) showed that irradiation of Q'H of 9 increased the signal intensity of C5H by 3.5%, establishing the indicated structure of 9. No such NOE enhancement of C5H was observed when Q-H of 8 was irradiated. Removal of the protecting groups of 9 by treatment with methanolic ammonia provided 10, which was converted to the DMT-phosphoramidite 12 via 11 as described above.
Binding properties of azole-2'-deoxyribonucleosides
In order to evaluate binding of azole 2'-deoxyribonucleosides in antiparallel triplexes, we tested the ability of the modified ohgonucleotides 17-20 to bind to a series of duplex targets, 21-24 (Fig. 4) . The sequence of these targets varies at the positions complementary to the sites of incorporation of the azoles in ohgonucleotides 17-20. Binding was tested by the electrophoretic band shift assay (2,4). As a positive control for triplex formation, we first tested the binding of triplex forming ohgonucleotide (TFO) 13 to 21 and TFO 15 to 22. In each case, the target is a perfect homopunne-homopyrimidine sequence, and the oligonucleotides are designed to bind to their respective targets in the antiparallel orientation (relative to the purine strand of the duplex), forming a series of GGC and TAT triplets. Triplexes 13*21 and 15*22 formed with high affinity (Fig. 5A) . Estimated association constants for the duplex to triplex transition were in the range of 2-5 x 10 9 M~'. In contrast, combinations of 13 + 24, or 15 + 23, did not lead to significant tnplex formation (Fig. 5B) . It is apparent that the presence of three CG inversions in 24 prevents binding of 13. Similarly, the three TA inversions in 23 prevents binding of 15. These comparisons illustrate the difficulties of forming triplexes at non-homopurine duplexes.
Binding of oligonucleotides 13-20 to duplex 23 is shown in Figure 6 . No detectable triplex formation was observed for any of the natural nucleosides (oligonucleotides 13-16) . However, all of the ohgonucleotides containing azoles (oligonucleotides 17-20) showed considerable binding to duplex 23. Oligonucleotides containing azole nucleosides (17-20), bind at least 100-1000-fold more tightly to duplex 23 (with association constants 8E7-5ES) than oligonucleotides containing only natural nucleosides (13-16) . However, the association constants of 17-20 to 23 are 10-30 times less than those of the 'natural' triplexes 13*21 and 15*22. These results indicate that the use of azole nucleosides can significantly expand the range of duplex targets amenable to antiparallel triplex formation. Table 2 summarizes apparent association constants determined from these experiments. A number of interesting features deserve comment First a comparison of binding affinities for oligonucleotides 13-16, containing all natural nucleosides, shows that G has the highest affinity for GC base pairs, and A and T have the highest affinities for AT base pairs. This is in general accord with previous data (9, 12, 29) . All of the TFOs containing simple azole-2'-deoxyribonucleosides demonstrate some propensity to bind to duplex targets containing GC base pairs, although the affinities are substantially lower than that of G. Surprisingly, none of the TFOs containing azoles exhibit any binding to duplex targets containing AT base pairs.
were not specifically designed to recognize particular base pairs in the duplex. Further study is warranted to determine the molecular basis for these observations. As described above, none of the TFOs containing natural nucleosides bind with appreciable affinity to TA base parrs, whereas all of the modified TFOs bind strongly. T binds to CG base pairs to form T»CG tnplets (15*24) as previously descnbed (9, 12) . TFOs containing imidazole and tetrazole also show substantial binding to duplexes containing CG base pairs, while triazole substitution exhibits weaker binding, and the pyrazole substituted TFO is apparently unable to bind.
Inspection of the binding affinities for ohgonucleotides containing the simple azole nucleosides reveals that there are two classes. Oligonucleotide 17, containing pyrazole-2'-deoxyribonucleoside, binds only to duplexes 21 and 23, containing GC and TA base pairs, respectively, and the binding is ~ 4-fold stronger to the duplex containing TA base pairs. In contrast, TFOs containing imidazole, triazole and tetrazole exhibit binding to duplexes containing GC, CG and TA base pairs, but are apparently unable to bind to duplexes containing AT base pairs. This degree of specificity was not anticipated, as these azoles "Listed values are apparent association constants for triplexes formed by the indicated combination of oligonucleotide and duplex Values are averages of at least two determinations, with duplicate values agreeing within a factor of two or less Where values are not given (-), little or no tnplex was detected, and the apparent association constant is estimated to be < 10* •The letter in parentheses represents the nucleoside of interest (bold letters in Fig 4) found in the indicated third strand oligonucleotide Nucleoside abbreviations are descnbed in the legend to Figure 4 The letters in parentheses indicate the base pair of interest (bold letters in Fig  4) for the indicated duplex
CONCLUSIONS
In conclusion, we have demonstrated that TFOs containing simple azole 2'-deoxy-ribonucleosides are capable of associating with duplexes containing CG and TA base pairs in antiparallel tnplexes with relatively high affinity. In general, these nucleosides are superior to natural nucleosides in this regard Although the current data do not address the mechanism of association, it is likely that multiple factors contribute. The potential for these azoles to maintain some degree of stacking interaction with neighbonng base triplets seems likely to contribute to the observed association properties. In addition, the small size of azoles relative to natural bases may reduce or eliminate unfavorable steric hindrance when the modified TFO was bound to the duplex having CG or TA base pairs.
Azole 2'-deoxyribonucleosides seem to be promising compounds for incorporation into TFOs for generalizing antiparallel Figure 6 . Band shift analysis of binding of oUgonuclendes 13-20 to duplex 23 DNA and ougonucleonde concentrations were as described in Figure 5 triple helix formation at non-homopurine targets. It is abundantly clear that the azole substitution permit binding of the modified TFO to the duplex sequence containing three TA base pairs. Pyrazole-2'-deoxyribonucleoside is of particular interest due to its strong discrimination against AT and CG base pairs, and weaker discrimination against GC base pairs. This is probably the first example of a nucleoside that is relatively specific for duplexes containing TA base pairs to form antiparallel triplexes. Although it is likely that sequence context effects will be observed, we expect that these compounds will also enhance antiparallel triplex formation with other targets containing TA (and CG) base pairs.
Based on the current riata, monocychc azoles could be viewed as a starting point in the design of more refined nucleosides. Addition of suitable exocyclic groups, perhaps designed to provide hydrogen bonding to the duplex bases, might enhance both affinity and specificity for a given base pair. Future design of such compounds would benefit greatly from an understanding of the molecular structure of an azole bound in a triplex. In that regard, we are presently exploring the use of 'H NMR to determine the mechanism of binding for one or more of these analogues.
